IL1B and peritonitis: In contrast, there was a remarkable decrease in leukocytes, neutrophils, and the expression of IL-6, IL-1β, and TNF-α in PMB-SA combination groups, indicating the attenuation of the inflammatory response in E. coli-induced peritonitis after PMB-SA combination therapy.